13F Holdings
中文EN

MLSS MILESTONE SCIENTIFIC INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 855683 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.9%
TTM net income YoY46.6%
TTM EPS YoY55.6%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin70.9%
Operating margin-40.0%
Net margin-38.3%
FCF margin-16.0%
EBITDA margin-39.2%

Returns

ROE-114.7%
ROA-46.1%
ROIC (approx.)-165.6%
Asset turnover1.20x

Leverage & solvency

Liabilities / assets47.3%
Debt / equity0.00x
Current ratio2.06x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.41x
Accruals ratio-27.1%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.22M$2.84M$2.16M$2.06M$2.36M$2.32M$2.23M$2.01M
Cost of revenue$614,218$930,871$598,009$556,313$719,247$705,860$584,985$502,452
Gross profit$1.61M$1.91M$1.56M$1.50M$1.64M$1.62M$1.65M$1.51M
R&D expense$10,413$6,609—$12,334$16,226$51,789$369,120$217,532
SG&A expense$2.32M$2.95M$2.37M$2.55M$2.74M$3.03M$3.26M$3.33M
Operating income-$746,292-$1.06M-$828,083-$1.08M-$1.13M-$1.48M-$2.00M-$2.04M
Pretax income-$747,545-$1.06M-$839,853-$1.09M-$1.15M-$1.48M-$1.99M-$2.04M
Income tax—————$0——
Net income-$747,545-$960,581-$759,861-$1.09M-$1.15M-$1.48M-$1.99M-$2.04M
EBITDA-$726,196-$1.04M-$808,629-$1.06M-$1.11M-$1.47M-$1.98M-$2.03M
EPS (basic)-0.01-0.01-0.01—-0.01-0.02-0.02—
EPS (diluted)-0.01-0.01-0.01—-0.01-0.02-0.02—
Weighted avg. shares (diluted)93.91M93.13M85.04M—82.32M82.05M81.85M—
Banking
Net interest income—————$1,521$3,267$6,752
Balance sheet
Cash & equivalents$1.32M$2.07M$1.20M$1.11M$1.35M$1.27M$2.25M$3.26M
Short-term investments———————$0
Receivables———————$475,376
Inventory$2.74M$3.09M$3.49M$3.78M$4.13M$3.90M$4.16M$3.71M
Current assets$6.77M$8.12M$7.35M$7.48M$8.11M$7.63M$8.62M$9.29M
PP&E, net$18,795$20,127$18,474$19,193$18,254$14,671$12,240$12,921
Intangibles$27,754$44,857$61,960$79,063$96,039$113,494$130,949$148,404
Total assets$6.94M$8.35M$7.96M$7.81M$8.49M$8.05M$9.09M$9.80M
Current liabilities$3.28M$4.40M$4.86M$3.94M$5.03M$3.77M$4.44M$3.74M
Total liabilities$3.29M$4.88M$5.68M$4.80M$5.94M$4.71M$4.63M$3.96M
Shareholders' equity$3.66M$3.85M$2.56M$3.01M$2.55M$3.34M$4.46M$5.83M
Shares outstanding90.61M88.76M80.45M80.45M78.56M78.56M78.20M78.01M
Cash flow statement
Operating cash flow-$746,301-$585,127$86,842-$226,129$81,775-$1.76M-$1.01M-$1.51M
Capital expenditure$1,662$4,139$1,632$3,116$6,232$4,472$1,304$3,528
Free cash flow-$747,963-$589,266$85,210-$229,245$75,543-$1.77M-$1.01M-$1.52M
Investing cash flow-$1,662-$4,139-$1,632-$3,116-$6,232-$4,472-$1,304-$3,528
Financing cash flow-$3,406$1.46M-$3,428-$3,414-$4,556$796,583-$2,278-$2,523
Depreciation & amortization$20,096$19,589$19,454$19,155$20,104$19,496$19,440$8,713
Stock-based compensation$99,444$309,578$256,683$99,168$363,083$159,678$330,787$339,852

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.